Concepts (130)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Colitis, Ulcerative | 7 | 2022 | 1920 | 0.770 |
Why?
|
| Ileum | 2 | 2019 | 557 | 0.690 |
Why?
|
| Proctocolectomy, Restorative | 5 | 2022 | 190 | 0.680 |
Why?
|
| Colonic Pouches | 4 | 2022 | 122 | 0.670 |
Why?
|
| Erythema Multiforme | 1 | 2019 | 31 | 0.670 |
Why?
|
| Metronidazole | 1 | 2019 | 232 | 0.600 |
Why?
|
| Thymoma | 1 | 2019 | 188 | 0.590 |
Why?
|
| Immunologic Deficiency Syndromes | 1 | 2019 | 548 | 0.500 |
Why?
|
| Crohn Disease | 4 | 2022 | 2278 | 0.490 |
Why?
|
| Anti-Bacterial Agents | 3 | 2019 | 7407 | 0.370 |
Why?
|
| Tumor Necrosis Factor-alpha | 3 | 2020 | 4340 | 0.350 |
Why?
|
| Staphylococcal Infections | 1 | 2019 | 1401 | 0.350 |
Why?
|
| Pouchitis | 2 | 2021 | 64 | 0.330 |
Why?
|
| Practice Guidelines as Topic | 2 | 2020 | 7400 | 0.260 |
Why?
|
| Leukocyte L1 Antigen Complex | 2 | 2020 | 93 | 0.210 |
Why?
|
| Anastomosis, Surgical | 3 | 2022 | 982 | 0.200 |
Why?
|
| Capsule Endoscopy | 1 | 2023 | 102 | 0.200 |
Why?
|
| Encephalitis, Viral | 1 | 2020 | 58 | 0.170 |
Why?
|
| Ileal Diseases | 1 | 2019 | 68 | 0.160 |
Why?
|
| Anemia, Iron-Deficiency | 1 | 2023 | 369 | 0.160 |
Why?
|
| Conflict of Interest | 1 | 2023 | 554 | 0.150 |
Why?
|
| Ulcer | 1 | 2019 | 204 | 0.140 |
Why?
|
| Drug Approval | 1 | 2024 | 812 | 0.140 |
Why?
|
| Feces | 2 | 2020 | 1490 | 0.140 |
Why?
|
| Radiography, Abdominal | 1 | 2019 | 534 | 0.130 |
Why?
|
| Fluid Therapy | 1 | 2019 | 578 | 0.120 |
Why?
|
| Colonoscopy | 2 | 2020 | 1395 | 0.120 |
Why?
|
| Irritable Bowel Syndrome | 1 | 2020 | 453 | 0.120 |
Why?
|
| Inflammatory Bowel Diseases | 2 | 2021 | 2421 | 0.120 |
Why?
|
| Remission Induction | 1 | 2020 | 2392 | 0.120 |
Why?
|
| Fatal Outcome | 1 | 2019 | 1838 | 0.120 |
Why?
|
| Myocarditis | 1 | 2022 | 792 | 0.120 |
Why?
|
| Immunologic Factors | 2 | 2020 | 1589 | 0.110 |
Why?
|
| Immunocompromised Host | 1 | 2019 | 858 | 0.110 |
Why?
|
| Secondary Prevention | 1 | 2019 | 1472 | 0.110 |
Why?
|
| Shock, Septic | 1 | 2019 | 769 | 0.100 |
Why?
|
| Clinical Clerkship | 1 | 2019 | 564 | 0.100 |
Why?
|
| Colitis | 1 | 2021 | 1234 | 0.100 |
Why?
|
| Educational Measurement | 1 | 2018 | 1250 | 0.100 |
Why?
|
| Chronic Disease | 2 | 2024 | 9319 | 0.090 |
Why?
|
| Clostridium Infections | 1 | 2018 | 557 | 0.090 |
Why?
|
| Colon | 1 | 2019 | 1791 | 0.090 |
Why?
|
| Recurrence | 2 | 2019 | 8457 | 0.090 |
Why?
|
| Receptors, Immunologic | 1 | 2015 | 1408 | 0.080 |
Why?
|
| Postoperative Complications | 3 | 2022 | 15637 | 0.080 |
Why?
|
| Pneumonia | 1 | 2019 | 2142 | 0.070 |
Why?
|
| Cytokines | 2 | 2020 | 7386 | 0.070 |
Why?
|
| Autoimmunity | 1 | 2015 | 1356 | 0.070 |
Why?
|
| NF-kappa B | 1 | 2015 | 2475 | 0.070 |
Why?
|
| Retrospective Studies | 8 | 2023 | 80674 | 0.070 |
Why?
|
| Students, Medical | 1 | 2019 | 1940 | 0.060 |
Why?
|
| Curriculum | 1 | 2018 | 3741 | 0.060 |
Why?
|
| Diagnosis, Differential | 1 | 2020 | 12976 | 0.060 |
Why?
|
| Physicians | 1 | 2023 | 4584 | 0.060 |
Why?
|
| Membrane Glycoproteins | 1 | 2015 | 3696 | 0.060 |
Why?
|
| Humans | 21 | 2024 | 761208 | 0.060 |
Why?
|
| Case-Control Studies | 2 | 2019 | 22174 | 0.060 |
Why?
|
| Genetic Predisposition to Disease | 2 | 2015 | 17897 | 0.050 |
Why?
|
| Adult | 8 | 2022 | 221119 | 0.050 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 3093 | 0.050 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 3215 | 0.050 |
Why?
|
| Female | 12 | 2023 | 392544 | 0.050 |
Why?
|
| Industry | 1 | 2023 | 364 | 0.040 |
Why?
|
| Inflammation | 2 | 2022 | 10759 | 0.040 |
Why?
|
| Pandemics | 1 | 2020 | 8663 | 0.040 |
Why?
|
| Museums | 1 | 2019 | 20 | 0.040 |
Why?
|
| Meta-Analysis as Topic | 1 | 2024 | 1381 | 0.040 |
Why?
|
| Extravasation of Diagnostic and Therapeutic Materials | 1 | 2019 | 101 | 0.040 |
Why?
|
| Internship and Residency | 1 | 2018 | 5885 | 0.040 |
Why?
|
| Ileostomy | 1 | 2019 | 121 | 0.040 |
Why?
|
| Quality of Life | 1 | 2019 | 13367 | 0.040 |
Why?
|
| Risk Factors | 3 | 2019 | 74239 | 0.040 |
Why?
|
| Male | 9 | 2023 | 360693 | 0.030 |
Why?
|
| Disclosure | 1 | 2023 | 747 | 0.030 |
Why?
|
| Hemoglobins | 1 | 2023 | 1525 | 0.030 |
Why?
|
| Gastrointestinal Tract | 1 | 2023 | 834 | 0.030 |
Why?
|
| Intestine, Small | 1 | 2023 | 1207 | 0.030 |
Why?
|
| Middle Aged | 6 | 2023 | 220853 | 0.030 |
Why?
|
| Gastrointestinal Hemorrhage | 1 | 2023 | 1116 | 0.030 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2015 | 15920 | 0.030 |
Why?
|
| Colectomy | 1 | 2020 | 686 | 0.030 |
Why?
|
| Feedback | 1 | 2018 | 790 | 0.030 |
Why?
|
| Receptors, Tumor Necrosis Factor, Type I | 1 | 2015 | 255 | 0.030 |
Why?
|
| Alzheimer Disease | 1 | 2015 | 8603 | 0.030 |
Why?
|
| Digestive System Surgical Procedures | 1 | 2019 | 571 | 0.030 |
Why?
|
| Phenotype | 2 | 2022 | 16575 | 0.030 |
Why?
|
| Aged | 3 | 2023 | 169288 | 0.030 |
Why?
|
| Treatment Failure | 1 | 2019 | 2643 | 0.030 |
Why?
|
| Endoscopy, Gastrointestinal | 1 | 2019 | 876 | 0.030 |
Why?
|
| Young Adult | 1 | 2019 | 59221 | 0.030 |
Why?
|
| Interprofessional Relations | 1 | 2019 | 990 | 0.030 |
Why?
|
| Physician's Role | 1 | 2019 | 920 | 0.020 |
Why?
|
| Signal Transduction | 1 | 2015 | 23416 | 0.020 |
Why?
|
| Mutation | 1 | 2015 | 30002 | 0.020 |
Why?
|
| Treatment Outcome | 3 | 2024 | 64681 | 0.020 |
Why?
|
| Severity of Illness Index | 2 | 2019 | 15841 | 0.020 |
Why?
|
| Amyloid | 1 | 2015 | 848 | 0.020 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2019 | 1878 | 0.020 |
Why?
|
| Vaccination | 1 | 2022 | 3369 | 0.020 |
Why?
|
| Acute Disease | 1 | 2020 | 7226 | 0.020 |
Why?
|
| Protein Transport | 1 | 2015 | 1958 | 0.020 |
Why?
|
| Drug Therapy, Combination | 1 | 2019 | 6304 | 0.020 |
Why?
|
| United States | 3 | 2024 | 72339 | 0.020 |
Why?
|
| Reoperation | 1 | 2019 | 4303 | 0.020 |
Why?
|
| Clinical Trials as Topic | 1 | 2024 | 8003 | 0.020 |
Why?
|
| Seizures | 1 | 2020 | 2965 | 0.020 |
Why?
|
| Patient Selection | 1 | 2019 | 4246 | 0.020 |
Why?
|
| Ambulatory Care | 1 | 2018 | 2770 | 0.020 |
Why?
|
| Microglia | 1 | 2015 | 1358 | 0.020 |
Why?
|
| Cell Nucleus | 1 | 2015 | 2881 | 0.020 |
Why?
|
| Contrast Media | 1 | 2019 | 5311 | 0.020 |
Why?
|
| Predictive Value of Tests | 1 | 2022 | 15308 | 0.020 |
Why?
|
| Referral and Consultation | 1 | 2018 | 3608 | 0.020 |
Why?
|
| Physician-Patient Relations | 1 | 2019 | 3253 | 0.020 |
Why?
|
| Attitude of Health Personnel | 1 | 2019 | 3885 | 0.020 |
Why?
|
| Sex Characteristics | 1 | 2015 | 2640 | 0.010 |
Why?
|
| Communication | 1 | 2018 | 3872 | 0.010 |
Why?
|
| Alleles | 1 | 2015 | 6857 | 0.010 |
Why?
|
| Clinical Competence | 1 | 2018 | 4788 | 0.010 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2015 | 4372 | 0.010 |
Why?
|
| Disease Progression | 1 | 2019 | 13511 | 0.010 |
Why?
|
| Cross-Sectional Studies | 1 | 2023 | 26071 | 0.010 |
Why?
|
| Multiple Sclerosis | 1 | 2015 | 3222 | 0.010 |
Why?
|
| Pregnancy | 1 | 2020 | 29893 | 0.010 |
Why?
|
| Age Factors | 1 | 2015 | 18384 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2020 | 41496 | 0.010 |
Why?
|
| Risk Assessment | 1 | 2019 | 24021 | 0.010 |
Why?
|
| Child | 1 | 2022 | 80152 | 0.010 |
Why?
|
| Time Factors | 1 | 2015 | 39957 | 0.010 |
Why?
|
| Prospective Studies | 1 | 2018 | 54435 | 0.010 |
Why?
|
Concepts
(130)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(6)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_